Core Laboratories NV (CLB) — Capital Reinvestment Ratio
Latest as of March 2026:
1.23x
Core Laboratories NV (CLB) has a Capital Reinvestment Ratio of 1.23x as of March 2026, meaning it reinvests 1% of its operating cash flow ($3.96 Million) in capital expenditures ($4.89 Million). See CLB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.23x
Capex / Operating Cash Flow
Operating Cash Flow
$3.96 Million
USD
Capital Expenditures
$4.89 Million
USD
Data as of
Mar 2026
Most recent filing
Core Laboratories NV Capital Reinvestment Ratio (1995–2025)
This chart tracks Core Laboratories NV's Capital Reinvestment Ratio across 30 annual periods.
Annual Capital Reinvestment Ratio for Core Laboratories NV (1995–2025)
Year-by-year Capital Reinvestment Ratio for Core Laboratories NV from 1995 to 2025. For live market cap and broader valuation context, see market value of Core Laboratories NV.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | $37.18 Million | $14.59 Million | ▲ +69.9% |
| 2024 | 0.23x | $56.39 Million | $13.03 Million | ▼ -45.9% |
| 2023 | 0.43x | $24.79 Million | $10.58 Million | ▲ +4.3% |
| 2022 | 0.41x | $24.96 Million | $10.22 Million | ▲ +10.6% |
| 2021 | 0.37x | $36.58 Million | $13.54 Million | ▲ +80.3% |
| 2020 | 0.21x | $57.87 Million | $11.88 Million | ▼ -17.5% |
| 2019 | 0.25x | $89.53 Million | $22.27 Million | ▲ +27.9% |
| 2018 | 0.19x | $111.83 Million | $21.74 Million | ▲ +28.7% |
| 2017 | 0.15x | $124.27 Million | $18.77 Million | ▲ +70.2% |
| 2016 | 0.09x | $131.89 Million | $11.70 Million | ▼ -19.8% |
| 2015 | 0.11x | $219.10 Million | $24.26 Million | ▼ -10.3% |
| 2014 | 0.12x | $303.45 Million | $37.44 Million | ▼ -5.5% |
| 2013 | 0.13x | $298.14 Million | $38.95 Million | ▼ -5.5% |
| 2012 | 0.14x | $237.20 Million | $32.80 Million | ▼ -6.4% |
| 2011 | 0.15x | $204.13 Million | $30.15 Million | ▲ +9.3% |
| 2010 | 0.14x | $205.83 Million | $27.80 Million | ▲ +40.1% |
| 2009 | 0.10x | $181.87 Million | $17.53 Million | ▼ -52.2% |
| 2008 | 0.20x | $155.21 Million | $31.30 Million | ▲ +5.0% |
| 2007 | 0.19x | $125.69 Million | $24.14 Million | ▼ -6.4% |
| 2006 | 0.21x | $120.31 Million | $24.68 Million | ▼ -19.7% |
| 2005 | 0.26x | $74.78 Million | $19.09 Million | ▲ +27.1% |
| 2004 | 0.20x | $54.20 Million | $10.89 Million | ▼ -46.8% |
| 2003 | 0.38x | $60.88 Million | $22.97 Million | ▼ -19.2% |
| 2002 | 0.47x | $40.98 Million | $19.14 Million | ▼ -54.5% |
| 2001 | 1.03x | $28.32 Million | $29.05 Million | ▼ -77.3% |
| 2000 | 4.52x | $7.27 Million | $32.84 Million | ▲ +6.5% |
| 1999 | 4.24x | $4.50 Million | $19.10 Million | ▲ +3.8% |
| 1998 | 4.09x | $6.60 Million | $27.00 Million | ▲ +471.4% |
| 1996 | 0.72x | $8.80 Million | $6.30 Million | ▲ +139.7% |
| 1995 | 0.30x | $7.70 Million | $2.30 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow